#ITI#Immunogenicity of poxvirus vector avian influenza vaccines in muscovy and pekin ducks#FTI#
#IRE#Fowlpox (FP)-vectored avian influenza (FP-AI) vaccines are used in 1-day-old chickens, but they have also recently been shown to be immunogenic in ducks. The objectives of this work were 1) to evaluate safety and to compare the immunogenicity in ducks of three poxvirus vectors (fowlpox, canarypox, and vaccinia) expressing the same hemagglutinin gene from an H5N1 isolate, 2) to study the effect of the dose of the FP-AI and the presence of an adjuvant in 1-day-old Pekin ducks on antibody response after a boost with inactivated vaccine given 3 wk later, and 3) to confirm the immunogenicity of such a heterologous prime-boost vaccination scheme in 1-day-old Muscovy ducks. Immunogenicity induced by the three poxvirus vectors was comparable, and the FP vector was selected for the other studies. As published previously, there was a strong dose effect of the FP-AI priming on the hemagglutination inhibition (HI) titers induced after the boost with an inactivated vaccine. In contrast, the two tested adjuvants did not significantly increase the activity of FP-AI priming. The heterologous prime-boost regimen given to both Muscovy and Pekin ducklings at 1 and 14 or 21 days of age, respectively, was shown to be at least as immunogenic as two administrations of inactivated vaccines given at 2 and 5 wk of age. However, HI antibody titers were of short duration for both vaccine schemes, and their persistence was heterogeneous among individual birds. Â© 2010 American Association of Avian Pathologists.#FRE#
#IPC#Avian influenza; Fowlpox; Immunogenicity; Muscovy ducks; Pekin ducks; Poxvirus vector; Vaccine#FPC#
#IRF#Alexander D.J., A review of avian influenza in different bird species, Vet. Microbiol., 74, pp. 3-13, (2000); 
Beato M.S., Toffan A., De Nardi R., Cristalli A., Terregino C., Cattoli G., Capua I., A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1, Vaccine, 25, pp. 4064-4072, (2007); 
Bublot M., Karaca K., Minke J., Pritchard N., Le Gros F.X., Poulet H., Audonnet J.C., Swayne D., Nordgren B., Current influenza vaccines for poultry and other animal species, Immunobiology of Influenza Infection: Approaches for An Emerging Zoonotic Disease, pp. 117-136, (2008); 
Bublot M., Pritchard N., Cruz J.S., Mickle T.R., Selleck P., Swayne D.E., Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge, Avian Dis., 51, pp. 498-500, (2007); 
Bublot M., Pritchard N., Swayne D.E., Selleck P., Karaca K., Suarez D.L., Audonnet J.C., Mickle T.R., Development and use of fowlpox vectored vaccines for avian influenza, Ann. N. Y. Acad. Sci., 1081, pp. 193-201, (2006); 
Cherbonnel M., Lamande J., Allee C., Schmitz A., Ogor K., Le Gall-Recule G., Le Bras M.O., Guillemoto C., Pierre I., Picault J.P., Jestin V., Virologic findings in selected free-range mule duck farms at high risk for avian influenza infection, Avian Dis., 51, pp. 408-413, (2007); 
Gilbert M., Xiao X., Chaitaweesub P., Kalpravidh W., Premashthira S., Boles S., Slingenbergh J., Avian influenza, domestic ducks and rice agriculture in Thailand, Agric. Ecosyst. Environ., 119, pp. 409-415, (2007); 
Gilbert M., Xiao X., Pfeiffer D.U., Epprecht M., Boles S., Czarnecki C., Chaitaweesub P., Kalpravidh W., Minh P.Q., Otte M.J., Martin V., Slingenbergh J., Mapping H5N1 highly pathogenic avian influenza risk in Southeast Asia, Proc. Natl. Acad. Sci. U. S. A., 105, pp. 4769-4774, (2008); 
Hulse-Post D.J., Sturm-Ramirez K.M., Humberd J., Seiler P., Govorkova E.A., Krauss S., Scholtissek C., Puthavathana P., Buranathai C., Nguyen T.D., Long H.T., Naipospos T.S., Chen H., Ellis T.M., Guan Y., Peiris J.S., Webster R.G., Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia, Proc. Natl. Acad. Sci. U. S. A., 102, pp. 10682-10687, (2005); 
Karaca K., Swayne D.E., Grosenbaugh D., Bublot M., Robles A., Spackman E., Nordgren R., Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats, Clin. Diagn. Lab. Immunol., 12, pp. 1340-1342, (2005); 
Kim J.K., Seiler P., Forrest H.L., Khalenkov A.M., Franks J., Kumar M., Karesh W.B., Gilbert M., Sodnomdarjaa R., Douangngeun B., Govorkova E.A., Webster R.G., Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks, J. Virol., 82, pp. 11374-11382, (2008); 
Kyriakis C.S., De Vleeschauwer A., Barbe F., Bublot M., Van Reeth K., Safety immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs, Vaccine, 27, pp. 2258-2264, (2009); 
Lundqvist M.L., Middleton D.L., Radford C., Warr G.W., Magor K.E., Immunoglobulins of the non-galliform birds: Antibody expression and repertoire in the duck, Dev. Comp. Immunol., 30, pp. 93-100, (2006); 
Middleton D., Bingham J., Selleck P., Lowther S., Gleeson L., Lehrbach P., Robinson S., Rodenberg J., Kumar M., Andrew M., Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks, Virology, 359, pp. 66-71, (2007); 
Minke J.M., Fischer L., Baudu P., Guigal P.M., Sindle T., Mumford J.A., Audonnet J.C., Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination, Vet. Immunol. Immunopathol., 111, pp. 47-57, (2006); 
Paoletti E., Applications of pox virus vectors to vaccination: An update, Proc. Natl. Acad. Sci. U. S. A., 93, pp. 11349-11353, (1996); 
Paoletti E., Taylor J., Meignier B., Meric C., Tartaglia J., Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC, Dev. Biol. Stand., 84, pp. 159-163, (1995); 
Prel A., Le Gall-Recule G., Cherbonnel M., Grasland B., Amelot M., Jestin V., Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks, Avian Dis., 51, pp. 484-489, (2007); 
Prel A., Le Gall-Recule G., Jestin V., Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks, Avian Pathol., 37, pp. 513-520, (2008); 
Songserm T., Jam-On R., Sae-Heng N., Meemak N., Hulse- Post D.J., Sturm-Ramirez K.M., Webster R.G., Domestic ducks and H5N1 influenza epidemic, Thailand, Emerg. Infect. Dis., 12, pp. 575-581, (2006); 
Steensels M., Bublot M., Van Borm S., De Vriese J., Lambrecht B., Richard-Mazet A., Chanavat-Bizzini S., Duboeuf M., Le Gros F.X., Berg Den T.Van, Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI, Vaccine, 27, pp. 646-654, (2009); 
Steensels M., Van Borm S., Lambrecht B., De Vriese J., Le Gros F.X., Bublot M., Berg Den T.Van, Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge, Avian Dis., 51, pp. 325-331, (2007); 
Sturm-Ramirez K.M., Hulse-Post D.J., Govorkova E.A., Humberd J., Seiler P., Puthavathana P., Buranathai C., Nguyen T.D., Chaisingh A., Long H.T., Naipospos T.S., Chen H., Ellis T.M., Guan Y., Peiris J.S., Webster R.G., Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia?, J Virol., 79, pp. 11269-11279, (2005); 
Swayne D.E., Beck J.R., Mickle T.R., Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus, Avian Dis., 41, pp. 910-922, (1997); 
Swayne D.E., Garcia M., Beck J.R., Kinney N., Suarez D.L., Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert, Vaccine, 18, pp. 1088-1095, (2000); 
Tian G., Zhang S., Li Y., Bu Z., Liu P., Zhou J., Li C., Shi J., Yu K., Chen H., Protective efficacy in chickens, geese and ducks of an H5N1- inactivated vaccine developed by reverse genetics, Virology, 341, pp. 153-162, (2005); 
Van Den Berg T., Lambrecht B., Marche S., Steensels M., Van Borm S., Bublot M., Influenza vaccines and vaccination strategies in birds, Comp. Immunol. Microbiol. Infect. Dis., 31, pp. 121-165, (2008); 
Van Der Goot J.A., Van Boven M., Stegeman A., Van De Water S.G., De Jong M.C., Koch G., Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine, Virology, 382, pp. 91-97, (2008); 
Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y., Evolution and ecology of influenza A viruses, Microbiol. Rev., 56, pp. 152-179, (1992); 
Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.J., Seiler P., Krauss S., Songserm T., The immunogenicity and efficacy against H5N1 challenge of reverse geneticsderived H5N3 influenza vaccine in ducks and chickens, Virology, 351, pp. 303-311, (2006)#FRF#
